Additionally, CEA and CA-125, though not entirely specific to lung cancer, have been consistently associated with NSCLC in biomarker panels, where their elevated levels contribute to improved diagnostic accuracy when combined with other markers. The gene discussed is MUC16; the disease is lung carcinoma.